Danske Bank A/s »

BioMarin Pharmaceutical shares owned by Danske Bank A/s

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Danske Bank A/s from 13F filings

Historical chart of Danske Bank A/s investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Danske Bank A/s consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Danske Bank A/s

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.3M 116k 54.16
2025-06-30 $6.0M 109k 54.97
2025-03-31 $6.0M 85k 70.69

More positions owned by Danske Bank A/s

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Cl B New (BRK.B)
Johnson & Johnson (JNJ)
Netflix (NFLX)

View all positions for Danske Bank A/s

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Millennium Management
Capital Research Global Investors
Morgan Stanley
Goldman Sachs Group
Dimensional Fund Advisors
Renaissance Technologies
Northern Trust

View all funds holding BioMarin Pharmaceutical